Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 042575/0116 | |
| Pages: | 8 |
| | Recorded: | 06/02/2017 | | |
Attorney Dkt #: | P120227US05 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
2
|
|
Patent #:
|
|
Issue Dt:
|
08/01/2017
|
Application #:
|
14947142
|
Filing Dt:
|
11/20/2015
|
Publication #:
|
|
Pub Dt:
|
05/19/2016
| | | | |
Title:
|
USE OF 2-METHYLENE-19-NOR-(20S)-1ALPHA,25-DIHYDROXYVITAMIN D3 TO PREVENT SECONDARY HYPERPARATHYROIDISM OR THE SYMPTOMS THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
08/14/2018
|
Application #:
|
15604069
|
Filing Dt:
|
05/24/2017
|
Publication #:
|
|
Pub Dt:
|
09/07/2017
| | | | |
Title:
|
Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat and Prevent Secondary Hyperparathyroidism in a Subject Having Renal Failure
|
|
Assignee
|
|
|
614 WALNUT STREET |
MADISON, WISCONSIN 53726 |
|
Correspondence name and address
|
|
MEREDITH NORIEGA
|
|
614 WALNUT STREET
|
|
13TH FLOOR
|
|
MADISON, WI 53726
|
Search Results as of:
09/24/2024 10:55 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|